Santen Pharmaceutical Co., Ltd. (4536)

Name: Santen Pharmaceutical Co., Ltd. (4536) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-10-02

Santen Pharmaceutical Co., Ltd. engages in the research and development, production, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally. The company operates through Medical drugs, Over-the-counter drugs, Medical equipment, and others segments.

Números-chave

Capitalização de mercado: JPY 529 billion
Receita (exercício encerrado em 2026-03-31): JPY 291.6B
Lucro líquido: JPY 37.4B
Margem bruta: 58.2%
Margem líquida: 12.8%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Receita total	JPY 291.6B	JPY 300.0B	JPY 302.0B	JPY 279.0B
Lucro bruto	JPY 169.7B	JPY 171.0B	JPY 178.7B	JPY 166.1B
Resultado Operacional (EBIT)	JPY 47.8B	JPY 46.9B	JPY 38.5B	(JPY 3.1B)
Resultado líquido	JPY 37.4B	JPY 36.3B	JPY 26.6B	(JPY 14.9B)

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 4536. /companies/us/4536

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.